198 related articles for article (PubMed ID: 20393138)
21. In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70.
Elkins KL; Cooper A; Colombini SM; Cowley SC; Kieffer TL
Infect Immun; 2002 Apr; 70(4):1936-48. PubMed ID: 11895957
[TBL] [Abstract][Full Text] [Related]
22. Rapid local expression of interleukin-12, tumor necrosis factor alpha, and gamma interferon after cutaneous Francisella tularensis infection in tularemia-immune mice.
Stenmark S; Sunnemark D; Bucht A; Sjöstedt A
Infect Immun; 1999 Apr; 67(4):1789-97. PubMed ID: 10085019
[TBL] [Abstract][Full Text] [Related]
23. Coactivating signals for the hepatic lymphocyte gamma interferon response to Francisella tularensis.
Wickstrum JR; Hong KJ; Bokhari S; Reed N; McWilliams N; Horvat RT; Parmely MJ
Infect Immun; 2007 Mar; 75(3):1335-42. PubMed ID: 17178781
[TBL] [Abstract][Full Text] [Related]
24. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.
Pammit MA; Raulie EK; Lauriano CM; Klose KE; Arulanandam BP
Infect Immun; 2006 Apr; 74(4):2063-71. PubMed ID: 16552035
[TBL] [Abstract][Full Text] [Related]
25. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis.
Kieffer TL; Cowley S; Nano FE; Elkins KL
Microbes Infect; 2003 Apr; 5(5):397-403. PubMed ID: 12737995
[TBL] [Abstract][Full Text] [Related]
26. Minimal requirements for murine resistance to infection with Francisella tularensis LVS.
Elkins KL; Rhinehart-Jones TR; Culkin SJ; Yee D; Winegar RK
Infect Immun; 1996 Aug; 64(8):3288-93. PubMed ID: 8757866
[TBL] [Abstract][Full Text] [Related]
27. Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen.
Wizel B; Starcher BC; Samten B; Chroneos Z; Barnes PF; Dzuris J; Higashimoto Y; Appella E; Sette A
J Immunol; 2002 Sep; 169(5):2524-35. PubMed ID: 12193722
[TBL] [Abstract][Full Text] [Related]
28. A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
De Pascalis R; Hahn A; Brook HM; Ryden P; Donart N; Mittereder L; Frey B; Wu TH; Elkins KL
PLoS One; 2018; 13(5):e0198140. PubMed ID: 29799870
[TBL] [Abstract][Full Text] [Related]
29. The contribution of reactive nitrogen and oxygen species to the killing of Francisella tularensis LVS by murine macrophages.
Lindgren H; Stenman L; Tärnvik A; Sjöstedt A
Microbes Infect; 2005 Mar; 7(3):467-75. PubMed ID: 15788155
[TBL] [Abstract][Full Text] [Related]
30. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis.
Fulop M; Mastroeni P; Green M; Titball RW
Vaccine; 2001 Aug; 19(31):4465-72. PubMed ID: 11483272
[TBL] [Abstract][Full Text] [Related]
31. The requirement of tumour necrosis factor-alpha and interferon-gamma for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum.
Sjöstedt A; North RJ; Conlan JW
Microbiology (Reading); 1996 Jun; 142 ( Pt 6)():1369-1374. PubMed ID: 8704976
[TBL] [Abstract][Full Text] [Related]
32. Myeloid differentiation factor-88 (MyD88) is essential for control of primary in vivo Francisella tularensis LVS infection, but not for control of intra-macrophage bacterial replication.
Collazo CM; Sher A; Meierovics AI; Elkins KL
Microbes Infect; 2006 Mar; 8(3):779-90. PubMed ID: 16513388
[TBL] [Abstract][Full Text] [Related]
33. Identification, recombinant expression, immunolocalization in macrophages, and T-cell responsiveness of the major extracellular proteins of Francisella tularensis.
Lee BY; Horwitz MA; Clemens DL
Infect Immun; 2006 Jul; 74(7):4002-13. PubMed ID: 16790773
[TBL] [Abstract][Full Text] [Related]
34. TCR alpha beta+ CD4- CD8- T cells differentiate extrathymically in an lck-independent manner and participate in early response against Listeria monocytogenes infection through interferon-gamma production.
Kadena T; Matsuzaki G; Fujise S; Kishihara K; Takimoto H; Sasaki M; Beppu M; Nakamura S; Nomoto K
Immunology; 1997 Aug; 91(4):511-9. PubMed ID: 9378488
[TBL] [Abstract][Full Text] [Related]
35. Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells.
Rhinehart-Jones TR; Fortier AH; Elkins KL
Infect Immun; 1994 Aug; 62(8):3129-37. PubMed ID: 8039881
[TBL] [Abstract][Full Text] [Related]
36.
Khan H; Bhargava V; Elkins KL
Microbiol Spectr; 2024 Jun; ():e0002824. PubMed ID: 38940590
[TBL] [Abstract][Full Text] [Related]
37. Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals.
Sjöstedt A; Sandström G; Tärnvik A
J Clin Microbiol; 1990 Jan; 28(1):43-8. PubMed ID: 1688874
[TBL] [Abstract][Full Text] [Related]
38. Type I IFN signaling constrains IL-17A/F secretion by gammadelta T cells during bacterial infections.
Henry T; Kirimanjeswara GS; Ruby T; Jones JW; Peng K; Perret M; Ho L; Sauer JD; Iwakura Y; Metzger DW; Monack DM
J Immunol; 2010 Apr; 184(7):3755-67. PubMed ID: 20176744
[TBL] [Abstract][Full Text] [Related]
39. Nasal Acai polysaccharides potentiate innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei Infections.
Skyberg JA; Rollins MF; Holderness JS; Marlenee NL; Schepetkin IA; Goodyear A; Dow SW; Jutila MA; Pascual DW
PLoS Pathog; 2012; 8(3):e1002587. PubMed ID: 22438809
[TBL] [Abstract][Full Text] [Related]
40. Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance.
Anthony LS; Kongshavn PA
Microb Pathog; 1987 Jan; 2(1):3-14. PubMed ID: 3507552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
